BWAY

MKT CAP:$619M

Brainsway Ltd

Market Cap

$619M

Healthcare·Medical Devices·🇺🇸 United States·NASDAQ

Healthcare·Medical Devices·🇺🇸·NASDAQ

Stock Price

$14.89+$5.25 (+54.38%)

Jul 15, 2026

52W High $17.1752W Low $5.74

Company Details

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major ...

Leadership

Hadar Levy

Chief Executive Officer

David Zacut M.D.Founder

Co-Founder & Vice-Chairman

Abraham Zangen Ph.D.Founder

Co-Founder, Member of Scientific Advisory Board & Director

Ido Marom

Chief Financial Officer

Colleen Hanlon Ph.D.

Vice President of Medical Affairs

Michael Cohen

Vice President of US Sales

Yiftach Roth Ph.D.Founder

Founder & Chief Scientific Officer

Dor Hagai

Vice President of Operations

Gilead Moiseyev Ph.D.

Chief Technology Officer

Menachem C. Klein Esq.

VP, General Counsel & Corporate Secretary

IPO Date

Oct 6, 1999

Website

www.brainsway.com

Key Metrics TTM

Revenue

$56M

+29.4% YoY

Net Income

$9M

EPS (Diluted)

Free Cash Flow

$13M

Revenue / Share

$2.95

Gross Margin

75.5%

Operating Margin

10.2%

Net Margin

15.7%

FCF Margin

22.6%

P/S

11.0x

P/E

70.2x

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee